The assessment and management of female sexual dysfunction;Abordagem das disfunções sexuais femininas

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 6, 2008, Pages 312-321

  Lara, Lúcia Alves Da Silva ^a,b   E Silva, Ana Carolina Japur De Sá Rosa ^a   Romão, Adriana Peterson Mariano Salata ^a   Junqueira, Flavia Raquel Rosa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Hormone replacement therapy; Sexual behavior; Sexual dysfunction, physiological therapy; Sexuality

Indexed keywords

EID: 51949086112     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-72032008000600008     Document Type: Review

References (99)

1. Mulhall J, King R, Glina S, Hvidsten K. Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey. J Sex Med. 2008;5(4):788-95.
2. Studd J. A comparison of 19th century and current attitudes to female sexuality. Gynecol Endocrinol. 2007;23(12):673-81.
3. Colson MH, Lemaire A, Pinton P, Hamidi K, Klein P. Sexual behaviors and mental perception, satisfaction and expectations of sex life in men and women in France. J Sex Med. 2006;3(1):121-31.
4. Smith LJ, Mulhall JP, Deveci S, Monaghan N, Reid MC. Sex after seventy: a pilot study of sexual function in older persons. J Sex Med. 2007;4(5):1247-53.
5. Martinez L. More education in the diagnosis and management of sexual dysfunction is needed. Fertil Steril. 2008;89(4):1035.
6. Abdo CHN, Oliveira Junior WM. O ginecologista brasileiro frente às queixas sexuais femininas: um estudo preliminar. RBM Rev Bras Med. 2002;59(3):179-86.
7. Berman L, Berman J, Felder S, Pollets D, Chhabra S, Miles M, et al. Seeking help for sexual function complaints: what gynecologists need to know about the female patient's experience. Fertil Steril. 2003;79(3):572-6.
8. Shindel AW, Ferguson GG, Nelson CJ, Brandes SB. The sexual lives of medical students: a single institution survey. J Sex Med. 2008;5(4):796-803.
9. Heiman JR, Guess MK, Connell K, Melman A, Hyde JS, Segraves RT, et al. Standards for clinical trials in sexual dysfunctions of women: research designs and outcomes assessment. J Sex Med. 2004;1(1):92-7.
10. Wagner G. Sexual medicine in the medical curriculum. Int J Androl. 2005;28 Suppl 2:7-8.
11. Hatzichristou D, Rosen RC, Broderick G, Clayton A, Cuzin B, Derogatis L, et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med. 2004;1(1):49-57.
12. Basson R, Althof S, Davis S, Fugl-Meyer K, Goldstein I, Leiblum S, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med. 2004;1(1):24-34.
13. Annon J. Behavioral treatment of sexual problems. New York: Harper & Row; 1976.
14. Frank JE, Mistretta P, Will J. Diagnosis and treatment of female sexual dysfunction. Am Fam Physician. 2008;77(5):635-42.
15. Taylor B, Davis S. Using the extended PLISSIT model to address sexual healthcare needs. Nurs Stand. 2006;21(11):35-40.
16. Vauth R, Härter M, Hohagen F, Kemmerich C, Herrmann JM, Haag G, et al. Management of mental health and primary care. Development and evaluation of a training program based on the PLISSIT approach. Nervenarzt. 1999;70(1):54-63.
17. Derogatis LR, Burnett AL. The epidemiology of sexual dysfunctions. J Sex Med. 2008;5(2):289-300.
18. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004;1(1):35-9.
19. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med. 2008;5(4):777-87.
20. Hayes RD, Dennerstein L, Bennett CM, Sidat M, Gurrin LC, Fairley CK. Risk factors for female sexual dysfunction in the general population: exploring factors associated with low sexual function and sexual distress. J Sex Med. 2008;5(7):1681-93.
21. Fisher HE, Aron A, Mashek D, Li H, Brown LL. Defining the brain systems of lust, romantic attraction, and attachment. Arch Sex Behav. 2002;31(5):413-9.
22. Bartels A, Zeki S. The neural basis of romantic love. Neuroreport. 2000;11(17):3829-34.
23. Fisher H, Aron A, Brown LL. Romantic love: an fMRI study of a neural mechanism for mate choice. J Comp Neurol. 2005;493(1):58-62.
24. Basson R. The complexities of female sexual arousal disorder: potential role of pharmacotherapy. World J Urol. 2002;20(2):119-26.
25. Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, et al. Revised definitions of women's sexual dysfunction. J Sex Med. 2004;1(1):40-8.
26. Basson R, Brotto LA, Laan E, Redmond G, Utian WH. Assessment and management of women's sexual dysfunctions: problematic desire and arousal. J Sex Med. 2005;2(3):291-300.
27. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril. 2001;76(3):456-60.
28. Hisasue S, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R, et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology. 2005;65(1):143-8.
29. Howard JR, O'Neill S, Travers C. Factors affecting sexuality in older Australian women: sexual interest, sexual arousal, relationships and sexual distress in older Australian women. Climacteric. 2006;9(5):355-67.
30. Bretschneider JG, McCoy NL. Sexual interest and behavior in healthy 80- to 102-year-olds. Arch Sex Behav. 1988;17(2):109-29.
31. Garcia-Segura LM, Diz-Chaves Y, Perez-Martin M, Darnaudéry M. Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology. 2007;32 Suppl 1:S57-61.
32. Rosa e Silva ACJS, Sá MFS. Efeitos dos esteróides sexuais sobre o humor e a cognição. Rev Psiquiatr Clin (São Paulo). 2006;33(2):60-7.
33. Stotland NL. Menopause: social expectations, women's realities. Arch Womens Ment Health. 2002;5(1):5-8.
34. González M, Viáfara G, Caba F, Molina T, Ortiz C. Libido and orgasm in middle-aged woman. Maturitas. 2006;53(1):1-10.
35. Beutel ME, Stöbel-Richter Y, Brähler E. Sexual desire and sexual activity of men and women across their lifespans: results from a representative German community survey. BJU Int. 2008;101(1):76-82.
36. Graziottin A. Prevalence and evaluation of sexual health problems-HSDD in Europe. J Sex Med. 2007;4 Suppl 3:211-9.
37. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause. 2006;13(1):46-56.
38. No authors listed. Child prostitution: family disintegration, necessary planning, the laziness of the elite. Planej Agora. 1993;9(239):4.
39. Grandjean C, Moran B. The impact of diabetes mellitus on female sexual well-being. Nurs Clin North Am. 2007;42(4):581-92; vi.
40. Kadioglu P, Yalin AS, Tiryakioglu O, Gazioglu N, Oral G, Sanli O, et al. Sexual dysfunction in women with hyperprolactinemia: a pilot study report. J Urol. 2005;174(5):1921-5.
41. Zárate A, Basurto L, Hernández M. Thyroid malfunction in women. Ginecol Obstet Mex. 2001;69:200-5.
42. Graham CA, Bancroft J, Doll HA, Greco T, Tanner A. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology. 2007;32(3):246-55.
43. Caruso S, Agnello C, Intelisano G, Farina M, Di Mari L, Cianci A. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception. 2004;69(3):237-40.
44. Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol. 1997;89(2):291-6.
45. Greenstein A, Ben-Aroya Z, Fass O, Militscher I, Roslik Y, Chen J, et al. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. J Sex Med. 2007;4(6):1679-83.
46. Zemishlany Z, Weizman A. The impact of mental illness on sexual dysfunction. Adv Psychosom Med. 2008;29:89-106.
47. Nobre PJ, Pinto-Gouveia J. Cognitive and emotional predictors of female sexual dysfunctions: preliminary findings. J Sex Marital Ther. 2008;34(4):325-42.
48. Sand M, Fisher WA. Women's endorsement of models of female sexual response: the nurses' sexuality study. J Sex Med. 2007;4(3):708-19.
49. Clayton AH. Epidemiology and neurobiology of female sexual dysfunction. J Sex Med. 2007;4 Suppl 4:260-8.
50. Abdo CH, Oliveira WM Jr, Moreira ED Jr, Fittipaldi JA. Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women-results of the Brazilian study on sexual behavior (BSSB). Int J Impot Res. 2004;16(2):160-6.
51. DeLamater J, Friedrich WN. Human sexual development. J Sex Res. 2002;39(1):10-4.
52. Junqueira FRR, Lara LAS, Romão APMS, Rosa e Silva ACJS, Romão GS, Ferriani RA. Implantação de um ambulatório de sexualidade em um serviço de ginecologia de hospital universitá rio: resultados após um ano. Reprod Clim. 2005;20:13-6.
53. Smith WJ, Beadle K, Shuster EJ. The impact of a group psychoeducational appointment on women with sexual dysfunction. Am J Obstet Gynecol. 2008;198(6):697.e1-6.
54. Althof SE, Leiblum SR, Chevret-Measson M, Hartmann U, Levine SB, McCabe M, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med. 2005;2(6):793-800.
55. Hartman LM. Effects of sex and marital therapy on sexual interaction and marital happiness. J Sex Marital Ther. 1983;9(2):137-51.
56. Goldstein I. Current management strategies of the postmenopausal patient with sexual health problems. J Sex Med. 2007;4 Suppl 3:235-53.
57. Brunelleschi S, Zeppegno P, Risso F, Cattaneo CI, Torre E. Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients. Pharmacol Res. 2003;48(4):405-9.
58. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol. 2000;163(3):888-93.
59. Kaplan HS. A nova terapia do sexo. Rio de Janeiro: Nova Fronteira; 1974.
60. Mishra G, Kuh D. Sexual functioning throughout menopause: the perceptions of women in a British cohort. Menopause. 2006;13(6):880-90.
61. Dixon KD, Dixon PN. The PLISSIT Model: care and management of patients' psychosexual needs following radical surgery. Lippincotts Case Manag. 2006;11(2):101-6.
62. Levin RJ. VIP, vagina, clitoral and periurethral glans-an update on human female genital arousal. Exp Clin Endocrinol. 1991;98(2):61-9.
63. Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology. 2006;147(1):61-9.
64. Delehanty R. Changes in assertiveness and changes in orgasmic response occurring with sexual therapy for preorgasmic women. J Sex Marital Ther. 1982;8(3):198-208.
65. Cohen BL, Barboglio P, Gousse A. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. J Sex Med. 2008;5(6):1418-23.
66. Bradway C, Strumpf N. Seeking care: women's narratives concerning long-term urinary incontinence. Urol Nurs. 2008;28(2):123-9.
67. Voorham-van der Zalm PJ, Lycklama A Nijeholt GA, Elzevier HW, Putter H, Pelger RC. "Diagnostic investigation of the pelvic floor": a helpful tool in the approach in patients with complaints of micturition, defecation, and/or sexual dysfunction. J Sex Med. 2008;5(4):864-71.
68. Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med. 2007;4(4 Pt 1):1001-8.
69. Gregersen N, Jensen PT, Giraldi AE. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Dan Med Bull. 2006;53(3):349-53.
70. Nelson HD. Menopause. Lancet. 2008;371(9614):760-70.
71. Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril. 2001;75(1):200-2.
72. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2003(4):CD001500.
73. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol. 1997;71(1):73-80.
74. Galhardo CL, Soares JM Jr, Simões RS, Haidar MA, Rodrigues de Lima G, Baracat EC. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol. 2006;33(2):85-9.
75. Gorodeski GI. Aging and estrogen effects on transcervical-transvaginal epithelial permeability. J Clin Endocrinol Metab. 2005;90(1):345-51.
76. Gorodeski GI, Pal D. Involvement of estrogen receptors alpha and beta in the regulation of cervical permeability. Am J Physiol Cell Physiol. 2000;278(4):C689-96.
77. Gorodeski GI. Vaginal-cervical epithelial permeability decreases after menopause. Fertil Steril. 2001;76(4):753-61.
78. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause. 2007;14(3 Pt 1):355-69.
79. Cayan F, Dilek U, Pata O, Dilek S. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med. 2008;5(1):132-8.
80. Conde DM, Pinto-Neto AM, Freitas Júnior R, Aldrighi JM. Qualidade de vida de mulheres com câncer de mama. Rev Bras Ginecol Obstet. 2006;28(3):195-204.
81. Derzko C, Elliott S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol. 2007;14 Suppl 1:S20-40.
82. Johnston SL, Farrell SA, Bouchard C, Farrell SA, Beckerson LA, Comeau M; SOGC Joint Committee-Clinical Practice Gynaecology and Urogynaecology. The detection and management of vaginal atrophy. J Obstet Gynaecol Can. 2004;26(5):503-15.
83. Borrelli AL, Casolaro AM, Esposito G, Berlingieri D. Biologic action of promestriene on the genital tract of the castrated rat. Minerva Ginecol. 1990;42(11):467-72.
84. Traish A, Guay AT, Spark RF; Testosterone Therapy in Women Study Group. Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary. J Sex Med. 2007;4(5):1223-34.
85. Braunstein GD. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies. J Sex Med. 2007;4(4 Pt 1):859-66.
86. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab. 2006;91(10):3697-710.
87. de Paula FJ, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms. Maturitas. 2007;56(1):69-77.
88. Basson R. Hormones and sexuality: current complexities and future directions. Maturitas. 2007;57(1):66-70.
89. Alexanderson C, Eriksson E, Stener-Victorin E, Lystig T, Gabrielsson B, Lönn M, et al. Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dihydrotestosterone. Endocrinology. 2007;148(11):5369-76.
90. Hanly MA. Submission, inhibition and sexuality: masochistic character and psychic change in Austen's Mansfield Park. Int J Psychoanal. 2005;86(Pt 2):483-501.
91. Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry. 2006;67(5):736-46.
92. Dobkin RD, Menza M, Marin H, Allen LA, Rousso R, Leiblum SR. Bupropion improves sexual functioning in depressed minority women: an open-label switch study. J Clin Psychopharmacol. 2006;26(1):21-6.
93. Bancroft J, Sartorius N. The effects of oral contraceptives on well-being and sexuality. Oxf Rev Reprod Biol. 1990;12:57-92.
94. Buffat J. Why women consult sexologists: an approach for practicing physicians. Rev Med Suisse. 2005;1(11):754-6, 759-61.
95. Meston CM, Levin RJ, Sipski ML, Hull EM, Heiman JR. Women's orgasm. Annu Rev Sex Res. 2004;15:173-257.
96. Badran W, Moamen N, Fahmy I, El-Karaksy A, Abdel-Nasser TM, Ghanem H. Etiological factors of unconsummated marriage. Int J Impot Res. 2006;18(5):458-63.
97. Reissing ED, Binik YM, Khalifé S, Cohen D, Amsel R. Etiological correlates of vaginismus: sexual and physical abuse, sexual knowledge, sexual self-schema, and relationship adjustment. J Sex Marital Ther. 2003;29(1):47-59.
98. Ghazizadeh S, Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstet Gynecol. 2004;104(5 Pt 1):922-5.
99. Fitzgerald MM, Schneider RA, Salstrom S, Zinzow HM, Jackson J, Fossel RV. Child sexual abuse, early family risk, and childhood parentification: pathways to current psychosocial adjustment. J Fam Psychol. 2008;22(2):320-4.